IGF-1 LR3 1mg Peptide | Long R3 Insulin-Like Growth Factor |

⚠️ ATTENTION: STRICTLY FOR LABORATORY RESEARCH USE ONLY.
This product is NOT FOR HUMAN CONSUMPTION, medical use, veterinary use, or diagnostic use. By purchasing, you agree to handle this compound in compliance with all local and federal regulations.

The Apex of Cellular Proliferation & Anabolic Signaling :

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) represents the absolute pinnacle of laboratory research concerning cellular regeneration, extreme muscular hypertrophy, and systemic tissue repair. In normal biological function, naturally occurring IGF-1 is the primary downstream mediator of Growth Hormone (GH). When the pituitary gland releases GH into the bloodstream, it signals the liver to synthesize and secrete IGF-1, which then travels to target tissues to stimulate cellular growth and repair.

However, endogenous (natural) IGF-1 possesses a severe biological limitation in a laboratory setting: it has an extremely short metabolic half-life of roughly 20 minutes, and over 95% of it is rapidly neutralized by Insulin-Like Growth Factor Binding Proteins (IGFBPs).

The “Long R3” Structural Modification: To solve this rapid degradation and create a viable compound for sustained research, molecular biologists engineered the LR3 variant. This advanced synthetic analog features an 83-amino-acid sequence with two critical structural modifications that completely alter its biological pharmacokinetics:

1. The “R3” Substitution: The substitution of the amino acid Arginine (Arg) for a Glutamic Acid (Glu) at position 3.

2. The “Long” Extension: The addition of a 13-amino-acid extension peptide directly at the N-terminus.

These precise structural alterations effectively render the molecule “invisible” to neutralizing IGFBPs. Because it successfully evades these binding proteins, the biological half-life of IGF-1 LR3 is radically extended from 20 minutes to an astonishing 20 to 30 hours. Furthermore, its receptor binding potency is increased by up to 300% compared to baseline IGF-1, making it an extraordinarily powerful tool for investigating sustained anabolic states in in-vitro and in-vivo models.

The Biochemistry of Hyperplasia & Tissue Regeneration

Unlike Growth Hormone Releasing Peptides (GHRPs) or Secretagogues (like CJC-1295 or Ipamorelin) which merely signal the body to produce more hormones, IGF-1 LR3 acts directly on the target tissues. It forcefully initiates the biological growth cascade without relying on the hypothalamic-pituitary axis.

Receptor Activation & The PI3K/AKT/mTOR Pathway

When introduced into a research model, IGF-1 LR3 binds directly to the Type 1 IGF Receptor (IGF-1R) located on the surface of target cells, particularly skeletal muscle and connective tissue. This binding triggers the intracellular PI3K/AKT signaling pathway, which subsequently activates mTOR (mammalian target of rapamycin). This pathway is the primary biological engine driving protein synthesis, cellular survival, and intense physical growth. By artificially sustaining this pathway for up to 30 hours, researchers can observe extreme hyperplastic and hypertrophic cellular responses that surpass normal genetic limitations.

Muscle Satellite Cell Activation (Hyperplasia vs. Hypertrophy)

One of the most profoundly studied mechanisms of IGF-1 LR3 is its unique ability to induce hyperplasia. While traditional anabolic stimuli cause hypertrophy (the enlargement of existing muscle cells), IGF-1 LR3 activates dormant muscle satellite cells. These stem-cell-like precursors awaken, proliferate, and fuse with existing muscle fibers, donating their nuclei. This not only repairs damaged muscle tissue at an accelerated rate but physically increases the cell count, permanently altering the structural capacity of the tissue.

Nutrient Partitioning & Anabolic Efficiency

IGF-1 LR3 acts as a master nutrient partitioner. It profoundly alters how the organism utilizes circulating glucose and amino acids. By upregulating specific glucose transporters (like GLUT4) on muscle cell membranes, it actively shuttles nutrients directly into muscle tissue to fuel the PI3K/AKT growth pathway. This simultaneously starves adipose (fat) cells of the lipid-building blocks they require, making it a critical compound for studying simultaneous muscle accrual and lipolysis (fat loss).

Primary Domains of Laboratory Investigation

1. Extreme Muscle Hypertrophy & Protein Synthesis

In performance, musculoskeletal, and physiological development research models, IGF-1 LR3 is intensely investigated for its unmatched ability to stimulate localized and systemic muscle growth. By forcing the activation of satellite cells and maintaining elevated protein synthesis, it allows researchers to study accelerated muscle repair after severe trauma, atrophy prevention, and the expansion of muscle tissue beyond standard physiological boundaries.
(Evidence Level: ⭐⭐⭐⭐☆ – Supported by extensive in-vitro and animal anabolic data).

2. Accelerated Tissue Repair & Connective Matrix Regeneration

Beyond skeletal muscle, IGF-1 signaling is a fundamental requirement for the repair of nearly all cellular tissues. Laboratory models utilize IGF-1 LR3 to investigate the rapid healing of damaged tendons, torn ligaments, and degraded cartilage. Its sustained biological activity encourages rapid extracellular matrix turnover, making it a critical compound in longevity, anti-aging, and physical rehabilitation research.
(Evidence Level: ⭐⭐⭐⭐☆).

3. Anti-Catabolic Action Under Metabolic Stress

During periods of severe caloric restriction, systemic illness, or physiological stress, biological systems typically become catabolic (breaking down muscle tissue to harvest amino acids for energy). Researchers utilize IGF-1 LR3 to study the total prevention of this tissue breakdown. Its powerful nutrient partitioning effects ensure that the organism remains in a preserved, anabolic state even under extreme metabolic deficits.
(Evidence Level: ⭐⭐⭐☆☆).

4. Skeletal & Neurological Support Studies

Emerging in-vitro studies suggest that sustained IGF-1 receptor activation plays a significant role in bone mineral density enhancement and neuroprotection. It is actively investigated for its potential to support motor neuron survival, enhance nerve regeneration following injury, and protect against age-related neuro-muscular decline.
(Evidence Level: ⭐⭐⭐☆☆).

Comparative Advantage: Direct Action vs Indirect Signaling

In advanced endocrine research, scientists must choose between utilizing GH secretagogues or direct growth factors. While compounds like Sermorelin or Ipamorelin stimulate the pituitary gland to release GH (which eventually leads to IGF-1 production), that process is subject to the body’s natural negative feedback loops and somatostatin inhibition.

IGF-1 LR3 bypasses the entire endocrine feedback loop. It delivers the final, active growth signal directly to the cellular receptors. This allows researchers to isolate the effects of the PI3K/AKT pathway without dealing with the variables of pituitary function, making it the most direct anabolic research peptide currently available.

Laboratory Specifications & Compound Profile

This ultra-premium formulation is synthesized for rigorous laboratory environments demanding absolute molecular stability, high purity, and sustained receptor binding affinity.

• Product Classification: Modified Synthetic Growth Factor Peptide.

• Molecular Weight: 9111.6 g/mol.

• Amino Acid Chain: 83 Amino Acids (Long R3 Sequence).

• Dosage / Yield: High-Capacity 1mg (1000mcg).

• Volume Capacity: 10ML standard clinical research vial format.

• Purity Standard: 99%+ (Independent Third-Party Lab Verified for structural integrity, correct protein folding, and receptor binding affinity).